Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Aethlon Medical (AEMD) over the last 15 years, with Q1 2025 value amounting to -$1.7 million.

  • Aethlon Medical's Cash from Operations rose 3480.07% to -$1.7 million in Q1 2025 from the same period last year, while for Mar 2025 it was -$7.6 million, marking a year-over-year increase of 2452.44%. This contributed to the annual value of -$7.6 million for FY2025, which is 2452.44% up from last year.
  • According to the latest figures from Q1 2025, Aethlon Medical's Cash from Operations is -$1.7 million, which was up 3480.07% from -$2.0 million recorded in Q4 2024.
  • Aethlon Medical's 5-year Cash from Operations high stood at -$1.7 million for Q1 2025, and its period low was -$3.1 million during Q1 2022.
  • For the 5-year period, Aethlon Medical's Cash from Operations averaged around -$2.4 million, with its median value being -$2.4 million (2023).
  • In the last 5 years, Aethlon Medical's Cash from Operations plummeted by 8801.08% in 2021 and then skyrocketed by 3480.07% in 2025.
  • Over the past 5 years, Aethlon Medical's Cash from Operations (Quarter) stood at -$2.7 million in 2021, then increased by 28.22% to -$2.0 million in 2022, then dropped by 21.87% to -$2.4 million in 2023, then grew by 15.44% to -$2.0 million in 2024, then rose by 16.82% to -$1.7 million in 2025.
  • Its Cash from Operations was -$1.7 million in Q1 2025, compared to -$2.0 million in Q4 2024 and -$2.2 million in Q3 2024.